Dynamic Technology Lab’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-5,000
| Closed | -$254K | – | 1083 |
|
|
2025
Q4 | $254K | Buy |
+5,000
| New | +$256K | 0.06% | 546 |
|
|
2025
Q2 | – | Sell |
-6,662
| Closed | -$463K | – | 1239 |
|
|
2025
Q1 | $463K | Sell |
6,662
-12,684
| -66% | -$1.05M | 0.07% | 513 |
|
|
2024
Q4 | $1.66M | Buy |
19,346
+5,795
| +43% | +$627K | 0.27% | 68 |
|
|
2024
Q3 | $1.61M | Sell |
13,551
-1,764
| -12% | -$235K | 0.17% | 168 |
|
|
2024
Q2 | $2.19M | Sell |
15,315
-17,952
| -54% | -$2.38M | 0.25% | 95 |
|
|
2024
Q1 | $4.27M | Buy |
33,267
+7,021
| +27% | +$836K | 0.46% | 8 |
|
|
2023
Q4 | $2.71M | Buy |
+26,246
| New | +$2.6M | 0.29% | 66 |
|
|
2023
Q3 | – | Sell |
-16,858
| Closed | -$1.36M | – | 1204 |
|
|
2023
Q2 | $1.36M | Buy |
+16,858
| New | +$1.38M | 0.17% | 167 |
|
|
2022
Q3 | – | Sell |
-8,860
| Closed | -$494K | – | 1401 |
|
|
2022
Q2 | $494K | Buy |
+8,860
| New | +$492K | 0.06% | 583 |
|
|
2021
Q4 | – | Sell |
-15,198
| Closed | -$730K | – | 1375 |
|
|
2021
Q3 | $730K | Buy |
15,198
+7,458
| +96% | +$361K | 0.09% | 388 |
|
|
2021
Q2 | $324K | Sell |
7,740
-354
| -4% | -$13.7K | 0.03% | 757 |
|
|
2021
Q1 | $273K | Buy |
+8,094
| New | +$288K | 0.03% | 829 |
|
|
2020
Q3 | – | Sell |
-9,600
| Closed | -$314K | – | 1233 |
|
|
2020
Q2 | $314K | Buy |
+9,600
| New | +$306K | 0.05% | 653 |
|
|
2020
Q1 | – | Sell |
-14,450
| Closed | -$418K | – | 1279 |
|
|
2019
Q4 | $418K | Buy |
+14,450
| New | +$400K | 0.07% | 532 |
|
|
2018
Q4 | – | Sell |
-22,130
| Closed | -$522K | – | 1208 |
|
|
2018
Q3 | $522K | Buy |
+22,130
| New | +$540K | 0.07% | 496 |
|
|
2018
Q2 | – | Sell |
-8,358
| Closed | -$205K | – | 1218 |
|
|
2018
Q1 | $205K | Sell |
8,358
-3,094
| -27% | -$81.2K | 0.03% | 891 |
|
|
2017
Q4 | $308K | Buy |
+11,452
| New | +$291K | 0.05% | 681 |
|
|
2016
Q4 | – | Sell |
-14,938
| Closed | -$311K | – | 1074 |
|
|
2016
Q3 | $311K | Buy |
+14,938
| New | +$370K | 0.08% | 484 |
|
|
2016
Q2 | – | Sell |
-10,082
| Closed | -$273K | – | 1073 |
|
|
2016
Q1 | $273K | Buy |
+10,082
| New | +$270K | 0.07% | 585 |
|
|
2015
Q1 | – | Sell |
-10,372
| Closed | -$221K | – | 813 |
|
|
2014
Q4 | $221K | Buy |
+10,372
| New | +$232K | 0.11% | 440 |
|
Other funds holding NVO
DAM
F
Dynamic Technology Lab's NVO Position: Q1 2026 in Review
Dynamic Technology Lab sold out of Novo Nordisk (NVO) in Q1 2026, closing a stake of 5,000 shares — an estimated $254K sold.
Dynamic Technology Lab first reported a position in NVO in Q4 2014 and held it in 20 quarters. The position peaked at $4.27M in Q1 2024. 1,277 funds tracked by Wall St. Rank hold NVO as of Q1 2026.
- Dynamic Technology Lab reported no remaining Novo Nordisk position as of Q1 2026 after selling out during the quarter.
- Dynamic Technology Lab sold 5,000 Novo Nordisk shares in Q1 2026, an estimated $254K.
- Dynamic Technology Lab first reported a position in Novo Nordisk in Q4 2014 and held it in 20 quarters.
- Dynamic Technology Lab's Novo Nordisk position peaked at $4.27M in Q1 2024.
- 1,277 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.
Based on Dynamic Technology Lab's 13F filing for Q1 2026, filed 15 May 2026.